University College London Featured PhD Programmes
Norwich Research Park Featured PhD Programmes
Imperial College London Featured PhD Programmes
Norwich Research Park Featured PhD Programmes
Cardiff University Featured PhD Programmes
"tumour"×
10 miles

tumour PhD Projects, Programs & Scholarships

We have 163 tumour PhD Projects, Programs & Scholarships

  • "tumour" ×
  • clear all
Order by 
Showing 1 to 10 of 163
  Chemically editable 3D tumour microenvironments to explore and exploit tumour immunity
  Dr O Pearce, Dr B Schumann
Application Deadline: 29 November 2019

Funding Type

PhD Type

Immunotherapy of cancers may offer progression free survival that is not seen with conventional chemotherapies. However, immunological barriers present within the tumour reduce response rates to therapy.
  Understanding interplay between genetic intra-tumour heterogeneity and the local tumour microenvironment
  Dr E Sahai
Application Deadline: 12 November 2019

Funding Type

PhD Type

This 4-year PhD studentship is offered in Dr Erik Sahai’s Group based at the Francis Crick Institute (the Crick). Intra-tumour heterogeneity represents a major challenge in the treatment of cancers.
  Neutrophils and Chemokine Signalling in the Tumour Immune Micro-environment and Progression
  Dr T Iwata
Applications accepted all year round

Funding Type

PhD Type

Checkpoint inhibitor immunotherapy is promising, however still requires an improvement in response and development of markers to predict the patients who would benefit from this therapy.
  Why do aged melanoma patients respond better to IT?
  Dr A Viros
Application Deadline: 3 January 2020

Funding Type

PhD Type

This 4 year PhD studentship offered in Dr Amaya Virós’s research group is based at the Cancer Research UK Manchester Institute, Alderley Park, Cheshire.
  Tumour microenvironment and colorectal cancer development: understanding the mechanisms of the tumour growth
  Prof D Kerr, Dr S Cai
Application Deadline: 10 January 2020

Funding Type

PhD Type

Our group has conducted a series of international adjuvant trials of chemotherapy for colorectal cancer (Kerr RS. et al, (2016), Lancet Oncol, 17, 1543 – 1557).
  Combined functional MRI and super-resolution ultrasound for non-invasive monitoring of tumour blood delivery during breast cancer radiotherapy.
  Prof M Tang, Dr N Somaiah, Dr M Blackledge
Application Deadline: 22 November 2019

Funding Type

PhD Type

Combined super-resolution ultrasound and functional MRI for non-invasive monitoring of tumour blood delivery during breast cancer radiotherapy.
  Novel Bio-Chips for real-time detection of acidification in the tumour microenvironment
  Dr P Georgiou, Dr C Bakal
Application Deadline: 22 November 2019

Funding Type

PhD Type

Novel Bio-Chips for real-time detection of acidification in the tumour microenvironment. Project Description. Cancers often return after a period of remission, and detection of these recurrences is key to begin follow-up treatments as early as possible.
  Understanding the mechanisms of neuroendocrine tumour response to radionuclide therapy
  Prof R Hicks, Assoc Prof C Cullinane
Applications accepted all year round

Funding Type

PhD Type

Neuroendocrine tumours (NET) represent a heterogeneous group of tumours that arise in specialized cells found throughout the body.
  GW4 BioMed MRC DTP PhD studentship: Development of a cancer-on-a-chip device to study the role of insulin-like growth factor binding protein-6 and immune cell tumour infiltration in breast cancer
  Dr U Jungwirth
Application Deadline: 25 November 2019

Funding Type

PhD Type

This project is one of a number that are in competition for funding from the ‘GW4 BioMed MRC Doctoral Training Partnership’ which is offering up to 18 studentships for entry in September 2020.
  Egr2 and 3 mediated T cell tolerance in cancer and their impact in immune checkpoint therapy
  Dr S Li
Applications accepted all year round

Funding Type

PhD Type

Tumour infiltrated lymphocytes (TILs) contain tumour reactive T cells and have been used as adoptive cell transfer therapy in patients which can mediate cancer regression.
Show 10 15 30 per page


FindAPhD. Copyright 2005-2019
All rights reserved.